Abstract:Background: We utilized our previous studies analyzing the reforms affecting the health sector developed in the 1990s by financial groups to frame the strategies implemented by the pharmaceutical industry to regain market positions and to understand the challenges that regulatory agencies are confronting. Methods: We followed an analytical approach for analyzing the process generated by the disputes between the financial groups and the pharmaceutical corporations and the challenges created to governmental regulation. We analyzed primary and secondary sources using situational and discourse analyses. We introduced the concepts of biomedicalization and biopedagogy, which allowed us to analyze how medicalization was radicalized. Results: In the 1990s, structural adjustment policies facilitated health reforms that allowed the entrance of multinational financial capital into publicly-financed and employer-based insurance. This model operated in contraposition to the interests of the medical industrial complex, which since the middle of the 1990s had developed silent reforms to regain authority in defining the health-ill-care model. These silent reforms radicalized the medicalization. Some reforms took place through deregulatory processes, such as allowing direct-to-consumer advertisements of prescription drugs in the United States. In other countries different strategies were facilitated by the lack of regulation of other media such as the internet. The pharmaceutical industry also has had a role in changing disease definitions, rebranding others, creating new ones, and pressuring for approval of treatments to be paid by public, employer, and private plans. In recent years in Brazil there has been a substantial increase in the number of judicial claims demanding that public administrations pay for new treatments. Conclusions: We found that the dispute for the hegemony of the health sector between financial and pharmaceutical companies has deeply transformed the sector. Patients converted into consumers are exposed to the biomedicalization of their lives helped by the biopedagogies, which using subtle mechanisms present discourses as if they are objective and created to empower consumers. The analysis of judicialization of health policies in Brazil could help to understand the complexity of the problem and to develop democratic mechanisms to improve the regulation of the health sector.

Medicalização da subjetividade e fetichismo psicofármaco: uma análise dos fundamentos

Medicalization of subjectivity and psychotropic drugs fetishism: an analysis of the fundamentals

Dificuldades no cuidado em saúde para as pessoas que fazem uso problemático de drogas: uma revisão integrativa

Uso de psicotrópicos: usuários, prescrições e prescritores. Estudo na cidade de Mar del Plata, Argentina (2021-2022)

Prescrição, oferta e acesso aos medicamentos para disfunção erétil: um paradoxo na saúde pública?

Cannabis Medicinal

Medication use for the management of professional performance: between invisibility and social normalisation

PODER EM MICHEL FOUCAULT E BYUNG-CHUL HAN: BIOPOLÍTICA, NEOLIBERALISMO E PSICOPOLÍTICA COMO DISPOSITIVOS PARA CONTROLAR CORPOS E PSIQUES NA SOCIEDADE INFORMACIONAL-DIGITAL

Reinventando a roda: Capoeira como dispositivo de cuidado em um Centro de Atenção Psicossocial Álcool e outras Drogas

USO DE SUBSTÂNCIAS PSICOATIVAS E EFEITOS ADVERSOS: DISTÚRBIOS DECORRENTES DO USO DE ÁLCOOL, CAFEÍNA, CANNABIS, COCAÍNA E NICOTINA.

Catadoras de materiais recicláveis: estratégias de resistência e medicamentos durante a pandemia de covid-19

Drug regulation and criminalization in Brazil

Práticas integrativas e complementares em saúde entre estudantes universitários: motivos de uso e de não uso

Desnortear, aquilombar e o antimanicolonial: três ideias-força para radicalizar a Reforma Psiquiátrica Brasileira

A territorialidade da Atenção Básica à Saúde do SUS: a difusão das clínicas médicas populares na Região Metropolitana de Belém, Pará, Brasil

The Subjective Experience of Using Medications: What We Know and the Paths Forward

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse

Beyond health: medicines, food supplements, energetics and the commodification of self-performance in Maputo

The creation of the health consumer: challenges on health sector regulation after managed care era

Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse

Patentes, acesso e produção local de medicamentos: reflexões a partir de experiências no SUS